Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts
Cell & Gene: The Podcast
00:00
Advancements in Allogeneic Cell Therapies
This chapter explores the process and benefits of allogeneic cell therapies over autologous therapies, particularly in the treatment of cancers such as non-Hodgkin's lymphoma. It discusses the challenges of accessibility and the scalability of manufacturing allogeneic treatments, which allow for a greater return on the use of healthy donor cells. The potential expansion of these therapies into new indications, including autoimmune diseases, is also highlighted, emphasizing their impact on healthcare delivery.
Transcript
Play full episode
